Bill > SB227

This bill proposes to cap the cost sharing (out-of-pocket expenses) for prescription insulin drugs in Ohio at $35 per 30-day supply, regardless of the amount or type of insulin needed. The bill defines a "prescription insulin drug" as a prescription drug containing insulin that is used to treat diabetes. Under this proposed law, health plan issuers would be prohibited from requiring patients to pay more than $35 for a 30-day supply of insulin when issuing, amending, or renewing health benefit plans on or after the bill's effective date. The cost sharing would be charged on a per-prescription-fill basis, which means each time a patient fills an insulin prescription, they would not be required to pay more than $35. This legislation aims to make insulin more affordable for people with diabetes by limiting the amount patients must pay out of pocket for this essential medication.